Presented positive interim data for 4D-150 in wet age-related macular degeneration (wet AMD) from PRISM Phase 1/2 clinical trial highlighting robust and durable clinical activity across diverse patien ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback